Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2

Area of Science:

• Immunology
• Infectious Diseases
• Biochemistry

Background:

• Human antimicrobial peptides (AMPs), including defensins and cathelicidin LL-37, are key components of the innate immune system.
• AMPs play a vital role in pulmonary defense against viral infections through diverse mechanisms.
• The COVID-19 pandemic necessitates urgent development of effective therapeutic strategies.

Purpose of the Study:

• To review the potential of AMPs and their derivatives as therapeutic agents against SARS-CoV-2.
• To explore how AMPs can be utilized in novel treatment strategies for COVID-19.
• To highlight the role of AMPs in modulating host immune responses during viral infections.

Main Methods:

• Review of existing literature on AMPs and their antiviral properties.
• Analysis of AMP mechanisms against viral particles and host cells.
• Exploration of combination therapies involving AMPs and other platforms like mesenchymal stem cells.

Main Results:

• AMPs exhibit multiple mechanisms for inhibiting viral infectivity, including direct virion binding and replication blocking.
• AMPs can modulate host cell receptors and act as chemokines to influence adaptive immunity.
• Mesenchymal stem cell therapy shows promise, potentially through released AMPs that regulate inflammation.

Conclusions:

• AMPs and their derivatives represent promising candidates for prophylactic and therapeutic use against COVID-19.
• Combining AMPs with other treatment modalities, such as stem cell therapy, may enhance efficacy.
• Further research into AMP-based strategies is crucial for combating SARS-CoV-2 and future viral threats.